首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal USP17L2 Antibody

  • 中文名: USP17L2抗体
  • 别    名: Ubiquitin carboxyl-terminal hydrolase 17, USP17, Deubiquitinating enzyme 17-like protein 2, Deubiquitinating protein 3, DUB-3, Ubiquitin carboxyl-terminal hydrolase 17-like protein 2, Ubiquitin thioesterase 17-like protein 2, Ubiquitin-specific-processing
货号: IPDX35007
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesUbiquitin carboxyl-terminal hydrolase 17, USP17, Deubiquitinating enzyme 17-like protein 2, Deubiquitinating protein 3, DUB-3, Ubiquitin carboxyl-terminal hydrolase 17-like protein 2, Ubiquitin thioesterase 17-like protein 2, Ubiquitin-specific-processing protease 17-like protein 2, USP17L2
Entrez GeneID377630
WB Predicted band size59.6kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenThis USP17L2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 476-503 amino acids from the C-terminal region of human USP17L2.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于USP17L2抗体的3篇参考文献示例(注:文献为虚构示例,实际研究中可能需要进一步检索验证):

---

1. **文献名称**:*USP17L2 regulates innate immune response through deubiquitination of MyD88*

**作者**:Chen et al. (2020)

**摘要**:本研究利用特异性USP17L2抗体,发现其通过去泛素化MyD88调控TLR信号通路,影响巨噬细胞的炎症因子释放,为自身免疫疾病治疗提供潜在靶点。

2. **文献名称**:*Characterization of a novel monoclonal antibody against human USP17L2 for cancer biomarker discovery*

**作者**:Smith et al. (2018)

**摘要**:团队开发了针对USP17L2的单克隆抗体,验证其在高通量免疫组化中的特异性,并发现USP17L2在肺癌组织中异常高表达,可能与肿瘤增殖相关。

3. **文献名称**:*USP17L2 modulates cell cycle progression by stabilizing cyclin D1*

**作者**:Wang et al. (2021)

**摘要**:通过USP17L2抗体介导的蛋白质免疫沉淀实验,证实其通过去泛素化稳定cyclin D1蛋白,促进G1/S期转换,提示其在癌症治疗中的意义。

---

**提示**:实际文献需通过PubMed、Web of Science等平台以“USP17L2 antibody”或“USP17L2 + deubiquitinase”为关键词检索,并注意基因别名(如USP17-like protein 2)。部分研究可能聚焦于USP17家族,需结合实验目的筛选。

背景信息

The USP17L2 antibody targets the ubiquitin-specific protease 17-like family member 2 (USP17L2), a deubiquitinating enzyme (DUB) involved in regulating protein stability and cellular signaling by removing ubiquitin moieties from substrate proteins. USP17L2 belongs to the USP17 subfamily, which is characterized by tandem repeats in their coding sequences and roles in processes such as cell proliferation, apoptosis, and immune responses. While USP17 family members are implicated in cancer, inflammation, and viral defense, USP17L2’s specific functions remain less defined, though it is hypothesized to modulate pathways like the NF-κB or Wnt signaling cascades. Antibodies against USP17L2 are primarily used in research to detect its expression, localization, and interaction partners via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Validation often includes knockout controls or siRNA knockdown to confirm specificity. These tools help explore USP17L2’s potential roles in diseases, particularly its regulatory effects on oncoproteins or immune-related targets. However, commercial availability may be limited due to its lesser-studied status compared to other DUBs. Researchers prioritize cross-reactivity checks due to high homology within the USP17 family.

客户数据及评论

折叠内容

大包装询价

×